APA (7th ed.) Citation

Oriol-Tordera, B., Esteve-Codina, A., Berdasco, M., Rosás-Umbert, M., Gonçalves, E., Duran-Castells, C., . . . Ruiz-Riol, M. (2022). Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome. EBioMedicine, 78, 103956. https://doi.org/10.1016/j.ebiom.2022.103956

Chicago Style (17th ed.) Citation

Oriol-Tordera, Bruna, et al. "Epigenetic Landscape in the Kick-and-kill Therapeutic Vaccine BCN02 Clinical Trial Is Associated with Antiretroviral Treatment Interruption (ATI) Outcome." EBioMedicine 78 (2022): 103956. https://doi.org/10.1016/j.ebiom.2022.103956.

MLA (9th ed.) Citation

Oriol-Tordera, Bruna, et al. "Epigenetic Landscape in the Kick-and-kill Therapeutic Vaccine BCN02 Clinical Trial Is Associated with Antiretroviral Treatment Interruption (ATI) Outcome." EBioMedicine, vol. 78, 2022, p. 103956, https://doi.org/10.1016/j.ebiom.2022.103956.